Relationship Between a Sepsis Intervention Bundle and In-Hospital Mortality Among Hospitalized Patients: A Retrospective Analysis of Real-World Data

Anesthesia and Analgesia
Priya A PrasadDavid Shimabukuro

Abstract

Sepsis is a systemic response to infection that can lead to tissue damage, organ failure, and death. Efforts have been made to develop evidence-based intervention bundles to identify and manage sepsis early in the course of the disease to decrease sepsis-related morbidity and mortality. We evaluated the relationship between a minimally invasive sepsis intervention bundle and in-hospital mortality using robust methods for observational data. We performed a retrospective cohort study at the University of California, San Francisco, Medical Center among adult patients discharged between January 1, 2012, and December 31, 2014, and who received a diagnosis of severe sepsis/septic shock (SS/SS). Sepsis intervention bundle elements included measurement of blood lactate; drawing of blood cultures before starting antibiotics; initiation of broad spectrum antibiotics within 3 hours of sepsis presentation in the emergency department or 1 hour of presentation on an inpatient unit; administration of intravenous fluid bolus if the patient was hypotensive or had a lactate level >4 mmol/L; and starting intravenous vasopressors if the patient remained hypotensive after fluid bolus administration. Poisson regression for a binary outcome variable ...Continue Reading

References

Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Apr 12, 2003·Critical Care Medicine·Mitchell M LevyUNKNOWN SCCM/ESICM/ACCP/ATS/SIS
Mar 23, 2004·American Journal of Epidemiology·Guangyong Zou
May 13, 2010·Critical Care : the Official Journal of the Critical Care Forum·Teresa CardosoAltamiro Costa-Pereira
Oct 4, 2011·Critical Care Medicine·Tara LaguPeter K Lindenauer
Feb 28, 2013·Critical Care Medicine·David F GaieskiBrendan G Carr
Mar 19, 2014·The New England Journal of Medicine·Donald M YealyDerek C Angus
Oct 2, 2014·Intensive Care Medicine·Mitchell M LevyR Phillip Dellinger
Oct 2, 2014·The New England Journal of Medicine·Sandra L PeakePatricia Williams
Mar 18, 2015·The New England Journal of Medicine·Paul R MounceyUNKNOWN ProMISe Trial Investigators
Nov 26, 2015·Journal of Critical Care·Jeremy StollerMunier Nazzal
Jan 21, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shruti K GohilUNKNOWN Centers for Disease Control and Prevention Epicenters Program

❮ Previous
Next ❯

Citations

Aug 29, 2019·High Altitude Medicine & Biology·Charles Haviland MizeKen Zafren
Oct 22, 2020·Mayo Clinic Proceedings. Innovations, Quality & Outcomes·Andreas H TaenzerUNKNOWN Members of the High Value Healthcare Collaborative

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.